Home Compliance GlaxoSmithKline: An Update on SFO Investigation ComplianceNews GlaxoSmithKline: An Update on SFO Investigation February 13, 2018 3 Share FacebookLinkedinTwitter You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Don’t Just Let the Dominoes Fall; Understand the Paths They Might Take Cyber Regulators Use “Carrots and Sticks” to Incentivize Healthcare Sector Cybersecurity Compliance Compliance DOJ Gets on the Data Analytics Bandwagon for FCPA